OrthoPediatrics Corp Selling and Marketing Expense
OrthoPediatrics Corp (KIDS) reported Selling and Marketing Expense of $21.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-05
- OrthoPediatrics Corp selling and marketing expense for the quarter ending 2026-06-30 was $21.29M, a 11.47% increase year-over-year.
- OrthoPediatrics Corp selling and marketing expense for the quarter ending 2026-03-31 was $18.47M, a 11.45% increase year-over-year.
- OrthoPediatrics Corp selling and marketing expense for the quarter ending 2025-12-31 was $18.40M, a 9.62% increase year-over-year.
- OrthoPediatrics Corp selling and marketing expense for the quarter ending 2025-09-30 was $18.65M, a 11.36% increase year-over-year.
- OrthoPediatrics Corp selling and marketing expense for fiscal 2025 was $72.73M, a 13.11% increase from fiscal 2024.
- OrthoPediatrics Corp selling and marketing expense for fiscal 2024 was $64.30M, a 21.72% increase from fiscal 2023.
- OrthoPediatrics Corp selling and marketing expense for fiscal 2023 was $52.82M, a 14.60% increase from fiscal 2022.
- OrthoPediatrics Corp selling and marketing expense for fiscal 2022 was $46.09M, a 16.18% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 6 month as first filed | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $21.29M 10-Q · filed 2026-08-05 | $39.76M 10-Q · filed 2026-08-05 | $58.16M derived: sum of 3 quarters · filed 2026-08-05 | $76.81M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $18.47M 10-Q · filed 2026-05-01 | $36.87M derived: sum of 2 quarters · filed 2026-05-01 | $55.52M derived: sum of 3 quarters · filed 2026-05-01 | $74.62M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $18.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $37.05M derived: sum of 2 quarters · filed 2026-03-04 | $56.15M derived: sum of 3 quarters · filed 2026-08-05 | $72.73M 10-K · filed 2026-03-04 | ||||
| 2025-09-30 | $18.65M 10-Q · filed 2025-10-29 | $37.76M derived: sum of 2 quarters · filed 2026-08-05 | $54.33M 10-Q · filed 2025-10-29 | $71.11M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $19.10M 10-Q · filed 2026-08-05 | $35.67M 10-Q · filed 2026-08-05 | $52.46M derived: sum of 3 quarters · filed 2026-08-05 | $69.21M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $16.57M 10-Q · filed 2026-05-01 | $33.36M derived: sum of 2 quarters · filed 2026-05-01 | $50.11M derived: sum of 3 quarters · filed 2026-05-01 | $66.70M derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $16.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $33.53M derived: sum of 2 quarters · filed 2026-03-04 | $50.13M derived: sum of 3 quarters · filed 2026-03-04 | $64.30M 10-K · filed 2026-03-04 | ||||
| 2024-09-30 | $16.75M 10-Q · filed 2025-10-29 | $33.34M derived: sum of 2 quarters · filed 2025-10-29 | $47.51M 10-Q · filed 2025-10-29 | $60.31M derived: sum of 4 quarters · filed 2026-03-04 | ||||
| 2024-06-30 | $16.59M 10-Q · filed 2025-08-06 | $30.76M 10-Q · filed 2025-08-06 | $43.56M derived: sum of 3 quarters · filed 2026-03-04 | $57.50M derived: sum of 4 quarters · filed 2026-03-04 | ||||
| 2024-03-31 | $14.17M 10-Q · filed 2025-05-08 | $26.97M derived: sum of 2 quarters · filed 2026-03-04 | $40.91M derived: sum of 3 quarters · filed 2026-03-04 | $54.44M derived: sum of 4 quarters · filed 2026-03-04 | ||||
| 2023-12-31 | $12.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $26.74M derived: sum of 2 quarters · filed 2026-03-04 | $40.27M derived: sum of 3 quarters · filed 2026-03-04 | $52.82M 10-K · filed 2026-03-04 | $51.40M 10-K · filed 2024-03-08 | |||
| 2023-09-30 | $13.94M 10-Q · filed 2024-11-07 | $13.58M 10-Q · filed 2023-11-07 | $27.48M derived: sum of 2 quarters · filed 2024-11-07 | $40.02M 10-Q · filed 2024-11-07 | $38.96M 10-Q · filed 2023-11-07 | $52.01M derived: sum of 4 quarters · filed 2025-03-05 | ||
| 2023-06-30 | $13.53M 10-Q · filed 2024-08-06 | $13.16M 10-Q · filed 2023-08-01 | $26.08M 10-Q · filed 2024-08-06 | $25.38M 10-Q · filed 2023-08-01 | $38.07M derived: sum of 3 quarters · filed 2025-03-05 | $49.99M derived: sum of 4 quarters · filed 2025-03-05 | ||
| 2023-03-31 | $12.55M 10-Q · filed 2024-05-07 | $12.22M 10-Q · filed 2023-05-02 | $24.54M derived: sum of 2 quarters · filed 2025-03-05 | $36.45M derived: sum of 3 quarters · filed 2025-03-05 | $48.88M derived: sum of 4 quarters · filed 2025-03-05 | |||
| 2022-12-31 | $11.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $23.91M derived: sum of 2 quarters · filed 2025-03-05 | $36.34M derived: sum of 3 quarters · filed 2025-03-05 | $46.09M 10-K · filed 2025-03-05 | $45.05M 10-K · filed 2023-03-01 | |||
| 2022-09-30 | $11.92M 10-Q · filed 2023-11-07 | $24.35M derived: sum of 2 quarters · filed 2023-11-07 | $34.11M 10-Q · filed 2023-11-07 | $44.09M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-06-30 | $12.43M 10-Q · filed 2023-08-01 | $22.19M 10-Q · filed 2023-08-01 | $32.17M derived: sum of 3 quarters · filed 2024-03-08 | $42.04M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-03-31 | $9.76M 10-Q · filed 2023-05-02 | $19.74M derived: sum of 2 quarters · filed 2024-03-08 | $29.61M derived: sum of 3 quarters · filed 2024-03-08 | $40.48M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2021-12-31 | $9.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $19.85M derived: sum of 2 quarters · filed 2024-03-08 | $30.72M derived: sum of 3 quarters · filed 2024-03-08 | $39.67M 10-K · filed 2024-03-08 | ||||
| 2021-09-30 | $9.86M 10-Q · filed 2022-11-01 | $20.74M derived: sum of 2 quarters · filed 2022-11-01 | $29.69M 10-Q · filed 2022-11-01 | $39.12M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $10.88M 10-Q · filed 2022-08-04 | $19.82M 10-Q · filed 2022-08-04 | $29.26M derived: sum of 3 quarters · filed 2023-03-01 | $38.49M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $8.95M 10-Q · filed 2022-05-05 | $18.38M derived: sum of 2 quarters · filed 2023-03-01 | $27.62M derived: sum of 3 quarters · filed 2023-03-01 | $33.24M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $9.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $18.67M derived: sum of 2 quarters · filed 2023-03-01 | $24.29M derived: sum of 3 quarters · filed 2023-03-01 | $31.85M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $9.24M 10-Q · filed 2021-11-04 | $14.86M derived: sum of 2 quarters · filed 2021-11-04 | $22.42M 10-Q · filed 2021-11-04 | $30.78M derived: sum of 4 quarters · filed 2022-03-03 | ||||
| 2020-06-30 | $5.62M 10-Q · filed 2021-08-05 | $13.18M 10-Q · filed 2021-08-05 | $21.54M derived: sum of 3 quarters · filed 2022-03-03 | $30.32M derived: sum of 4 quarters · filed 2022-03-03 | ||||
| 2020-03-31 | $7.56M 10-Q · filed 2021-05-06 | $15.92M derived: sum of 2 quarters · filed 2022-03-03 | $24.70M derived: sum of 3 quarters · filed 2022-03-03 | $32.30M derived: sum of 4 quarters · filed 2022-03-03 | ||||
| 2019-12-31 | $8.36M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $17.13M derived: sum of 2 quarters · filed 2022-03-03 | $24.74M derived: sum of 3 quarters · filed 2022-03-03 | $31.28M 10-K · filed 2022-03-03 | ||||
| 2019-09-30 | $8.77M 10-Q · filed 2020-11-05 | $16.38M derived: sum of 2 quarters · filed 2020-11-05 | $22.92M 10-Q · filed 2020-11-05 | $29.48M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-06-30 | $7.61M 10-Q · filed 2020-08-06 | $14.15M 10-Q · filed 2020-08-06 | $20.71M derived: sum of 3 quarters · filed 2021-03-11 | $27.86M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-03-31 | $6.55M 10-Q · filed 2020-05-06 | $13.11M derived: sum of 2 quarters · filed 2021-03-11 | $20.25M derived: sum of 3 quarters · filed 2021-03-11 | $27.03M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2018-12-31 | $6.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $13.71M derived: sum of 2 quarters · filed 2021-03-11 | $20.48M derived: sum of 3 quarters · filed 2021-03-11 | $26.56M 10-K · filed 2021-03-11 | ||||
| 2018-09-30 | $7.15M 10-Q · filed 2019-11-08 | $13.93M derived: sum of 2 quarters · filed 2019-11-08 | $20.00M 10-Q · filed 2019-11-08 | $25.41M derived: sum of 4 quarters · filed 2020-03-05 | ||||
| 2018-06-30 | $6.78M 10-Q · filed 2019-08-13 | $12.86M 10-Q · filed 2019-08-13 | $18.26M derived: sum of 3 quarters · filed 2020-03-05 | $23.89M derived: sum of 4 quarters · filed 2020-03-05 | ||||
| 2018-03-31 | $6.08M 10-Q · filed 2019-05-09 | $11.48M derived: sum of 2 quarters · filed 2020-03-05 | $17.12M derived: sum of 3 quarters · filed 2020-03-05 | $22.42M derived: sum of 4 quarters · filed 2020-03-05 | ||||
| 2017-12-31 | $5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $11.04M derived: sum of 2 quarters · filed 2020-03-05 | $16.34M derived: sum of 3 quarters · filed 2020-03-05 | $20.53M 10-K · filed 2020-03-05 | ||||
| 2017-09-30 | $5.63M 10-Q · filed 2018-10-31 | $10.93M derived: sum of 2 quarters · filed 2018-10-31 | $15.12M 10-Q · filed 2018-10-31 | $19.38M derived: sum of 4 quarters · filed 2019-03-07 | ||||
| 2017-06-30 | $5.30M 10-Q · filed 2018-08-09 | $9.49M 10-Q · filed 2018-08-09 | $13.75M derived: sum of 3 quarters · filed 2019-03-07 | $18.04M derived: sum of 4 quarters · filed 2019-03-07 | ||||
| 2017-03-31 | $4.19M 10-Q · filed 2018-05-15 | $8.45M derived: sum of 2 quarters · filed 2019-03-07 | $12.74M derived: sum of 3 quarters · filed 2019-03-07 | |||||
| 2016-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $8.55M derived: sum of 2 quarters · filed 2019-03-07 | $16.66M 10-K · filed 2019-03-07 | |||||
| 2016-09-30 | $4.29M 10-Q · filed 2017-11-13 | $12.40M 10-Q · filed 2017-11-13 | ||||||
| 2015-12-31 | $15.03M 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |